According to a report by TechSci Research titled “Global Bionic Eye Market: Type, Technology, End User, Company, Region, Forecast & Opportunities, 2028,” the global bionic eye market is expected to experience steady growth over the next five years. The bionic eye is a medical device that helps restore vision to patients suffering from vision impairment or blindness. The increasing number of people with eye problems who cannot afford treatment has created a need for supportive government policies, which are expected to drive the demand for bionic eyes worldwide.
The COVID-19 pandemic, declared by the World Health Organization, has had adverse effects on countries around the world. Lockdown restrictions and precautionary measures imposed by authorities have affected the population, with COVID-19 patients experiencing symptoms such as shortness of breath, coughing, and sneezing. As the number of affected patients increased, hospital capacity was expanded to accommodate them. Patients with visual problems avoided elective surgical procedures to prioritize their safety. Additionally, disruptions in the supply chain due to import and export restrictions are expected to have a negative impact on the bionic eye market. However, once the pandemic is under control, the market is expected to regain momentum.
Browse XX Figures spread through XX Pages and an in-depth TOC on “Global Bionic Eye Market”.
The global bionic eye market is segmented based on type, technology, end user, regional distribution, and company. In terms of end users, hospitals, ophthalmic clinics, and others are the major segments. The hospital segment is expected to hold the largest market share during the forecast period of 2022-2028. The presence of numerous hospitals worldwide and the high influx of patients contribute to the demand for bionic eyes. Hospitals are well-equipped with trained ophthalmologists, laboratories, and advanced technology for effective patient treatment. Supportive government policies and favorable reimbursement plans are expected to drive the demand for bionic eyes globally. Collaborations between hospitals and market players for conducting clinical trials also foster the high growth of the bionic eye market. In terms of technology, the market is divided into electronic and mechanical. The electronic segment is expected to dominate the bionic eye market in the next five years due to higher adoption rates and increasing number of clinical trials. Electronic bionic eyes are battery-powered devices that capture video signals from an integrated camera and convert them into electrical stimulation data, which is then transmitted to an implanted stimulation device. In terms of regional analysis, North America is expected to hold a significant share in the bionic eye market. Favorable reimbursement policies, a well-developed healthcare system, and a large number of ongoing research and development activities drive the demand for bionic eyes in the region.
Leading players in the global bionic eye market include Second Sight Medical Products Inc., Nidek Co. Ltd., Nano Retina Ltd., MetaModal LLC, Biomedical Technologies S.L., Bionic Vision Technologies, Pixium Vision S.A., Monash Vision Group, iBionics, and Optobionics Corporation. Manufacturers are increasingly focusing on research and development to drive market growth. They are introducing technologically advanced bionic eyes to meet evolving customer demands for improved efficiency and durability.
“Major market players are making significant investments in technology development and infrastructure upgrades, which are expected to drive the demand for bionic eyes. The launch of novel advanced bionic eyes, equipped with features such as video processing units, face detection systems, 3D vision with stereo cameras mounted on eyewear, and integrated navigation and hurdle detection technology, further fuels the demand. The increasing prevalence of chronic diseases such as hypertension and diabetes, which adversely affect eye health, and the growing awareness of the benefits of adopting bionic eyes are expected to propel market growth until 2028,” said Mr. Karan Chechi, Research Director at TechSci Research, a research-based global management consulting firm.
“Global Bionic Eye Market By Type (Implant v/s External) By Technology (Electronic v/s Mechanical) By End User (Hospitals, Ophthalmic Clinics, Others) By Company, By Region, Forecast & Opportunities, 2028” has evaluated the future growth potential of global bionic eye market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of global bionic eye market.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7572
Related Reports:
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]